From: Randomized phase II exploratory study of prophylactic amifostine in cancer patients who receive radical radiotherapy to the pelvis
A + R (N = 21)
R (N = 23)
Endoscopically rated colitis
Acute
Late
Grade 1
-
2
Grade 2
6
Grade 3
1
Grade 4
Totals (%)
(0%)+
7
(28,6%)
4
(17,4%)+
8
(34,8%)